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tress is commonly defined as a state of real or
perceived threat to homeostasis.Maintenance of home-
ostasis in the presence of aversive stimuli (stressors)
requires activation of a complex range of responses
involving the endocrine, nervous, and immune systems,
collectively known as the stress response.
1,2Activation of
the stress response initiates a number of behavioral and
physiological changes that improve an individual’s
chance of survival when faced with homeostatic chal-
lenges.Behavioral effects of the stress response include
increased awareness,improved cognition,euphoria,and
enhanced analgesia.
1,3 Physiological adaptations initiated
by activation of this system include increased cardio-
vascular tone,respiratory rate,and intermediate metab-
olism, along with inhibition of general vegetative func-
tions such as feeding, digestion, growth, reproduction,
and immunity.
4,5 Due to the wide array of physiologic
and potentially pathogenic effects of the stress response,
a number of neuronal and endocrine systems function to
tightly regulate this adaptive process.
Anatomy of the stress response
The anatomical structures that mediate the stress
response are found in both the central nervous system
and peripheral tissues. The principal effectors of the
stress response are localized in the paraventricular
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Animals respond to stress by activating a wide array of
behavioral and physiological responses that are collec-
tively referred to as the stress response. Corticotropin-
releasing factor (CRF) plays a central role in the stress
response by regulating the hypothalamic-pituitary-adrenal
(HPA) axis. In response to stress, CRF initiates a cascade of
events that culminate in the release of glucocorticoids
from the adrenal cortex. As a result of the great number
of physiological and behavioral effects exerted by gluco-
corticoids, several mechanisms have evolved to control
HPA axis activation and integrate the stress response.
Glucocorticoid feedback inhibition plays a prominent role
in regulating the magnitude and duration of glucocorti-
coid release. In addition to glucocorticoid feedback, the
HPA axis is regulated at the level of the hypothalamus by
a diverse group of afferent projections from limbic, mid-
brain, and brain stem nuclei. The stress response is also
mediated in part by brain stem noradrenergic neurons,
sympathetic andrenomedullary circuits, and parasympa-
thetic systems. In summary, the aim of this review is to dis-
cuss the role of the HPA axis in the integration of adap-
tive responses to stress. We also identify and briefly
describe the major neuronal and endocrine systems that
contribute to the regulation of the HPA axis and the main-
tenance of homeostasis in the face of aversive stimuli.
© 2006, LLS SAS Dialogues Clin Neurosci. 2006;8:383-395.nucleus (PVN) of the hypothalamus,the anterior lobe of
the pituitary gland, and the adrenal gland.This collec-
tion of structures is commonly referred to as the hypo-
thalamic-pituitary-adrenal (HPA) axis (Figure 1).I n
addition to the HPA axis, several other structures play
important roles in the regulation of adaptive responses
to stress.These include brain stem noradrenergic neu-
rons, sympathetic andrenomedullary circuits, and
parasympathetic systems.
5-7
The HPA axis
Hypophysiotropic neurons localized in the medial par-
vocellular subdivision of the PVN synthesize and secrete
corticotropin-releasing factor (CRF), the principle reg-
ulator of the HPA axis.
8,9 In response to stress, CRF is
released into hypophysial portal vessels that access the
anterior pituitary gland.Binding of CRF to its receptor
on pituitary corticotropes induces the release of adreno-
corticotropic hormone (ACTH) into the systemic circu-
lation.The principal target for circulating ACTH is the
adrenal cortex, where it stimulates glucocorticoid syn-
thesis and secretion from the zona fasciculata.
Glucocorticoids are the downstream effectors of the
HPA axis and regulate physiological changes through
ubiquitously distributed intracellular receptors.
10,11 The
biological effects of glucocorticoids are usually adaptive;
however,inadequate or excessive activation of the HPA
axis may contribute to the development of patholo-
gies.
10,12
The CRF family of peptides
Corticotropin-releasing factor is a 41 amino acid peptide
that was originally isolated from ovine hypothalamic tis-
sue in 1981.
8 Since this initial identification, CRF has
been shown to be the primary regulator of ACTH release
from anterior pituitary corticotropes
9 and has also been
implicated in the regulation of the autonomic nervous
system,learning and memory,feeding,and reproduction-
related behaviors.
13-19 CRF is widely expressed through-
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Selected abbreviations and acronyms
ACTH adrenocorticotropic hormone
BNST bed nucleus of stria terminalis
cAMP cyclic adenosine monophosphate
CeA central nuclei of amygdala
CNS central nervous system
CRF corticotropin-releasing factor
DMH dorsomedial hypothalamic nucleus
GR glucocorticoid receptor
HPA hypothalamic-pituitary-adrenal
LC locus coeruleus
LS lateral septum
MeA medial nuclei of the amygdala
NTS nucleus of solitary tract
POA preoptic area
PVN paraventricular nucleus
SFO subfornical organ
Figure 1. Schematic representation of the hypothalamic-pituitary-
adrenal (HPA) axis. Hypophysiotropic neurons localized in
the paraventricular nucleus (PVN) of the hypothalamus
synthesize corticotropin-releasing factor (CRF) and vaso-
pressin (AVP). In response to stress, CRF is released into
hypophysial portal vessels that access the anterior pituitary
gland. Binding of CRF to the CRF type 1 receptor (CRFR1)
on pituitary corticotropes activates cyclic adenosine
monophosphate (cAMP) pathway events that induce the
release of adrenocorticotropic hormone (ACTH) into the
systemic circulation. In the presence of CRF, AVP elicits syn-
ergistic effects on ACTH release that are mediated through
the vasopressin V1b receptor. Circulating ACTH binds to the
melanocortin type 2 receptor (MC2-R) in the adrenal cor-
tex where it stimulates glucocorticoid synthesis and secre-
tion into the systemic circulation. Glucocorticoids regulate
physiological events and inhibit further HPA axis activa-
tion (red lines) through intracellular receptors that are
widely distributed throughout the brain and peripheral
tissues. IP3, inositol triphosphate; DAG, diacylglycerol
MC2-R MC2-R
Portal system
Anterior lobe
CRFR1 cAMP
cAMP cAMP
V1B IP3, DAG
Glucocorticoids
ACTH
Hypothalamus
Adrenal
Pituitary
PVN PVN
III
AVP AVP
CRF CRFout the central nervous system (CNS) and in a number
of peripheral tissues.In the brain,CRF is concentrated
in the medial parvocellular subdivision of the PVN and
is also localized in the olfactory bulb,bed nucleus of the
stria terminalis (BNST), medial preoptic area, lateral
hypothalamus, central nucleus of the amygdala,
Barington’s nucleus,dorsal motor complex,and inferior
olive.
20 In the periphery,CRF has been detected in the
adrenal gland,testis,placenta,gastrointestinal tract,thy-
mus,and skin.
21-23
Three additional members of the CRF peptide family have
recently been identified.These include urocortin (Ucn) 1
24
and the recently cloned Ucn 2
25 and Ucn 3,
26 which are also
known as stresscopin-related peptide and stresscopin,
27
respectively.In the mammalian brain,Ucn 1 is predomi-
nantly expressed in the Edinger-Westphal nucleus
24 and
Ucn 2 expression is restricted to the PVN and locus
coeruleus.
25 Ucn 3 has a wider distribution in the brain and
is localized in the perifornical area of the hypothalamus,
BNST, lateral septum (LS), and amygdala.
28 The wide-
spread anatomical distribution of CRF and the urocortins
correlates well with the diverse array of physiological func-
tions associated with this peptide family.
CRF receptors
The physiological actions of the CRF family of peptides
are mediated through two distinct receptor subtypes
belonging to the class B family of G-protein coupled
receptors.
29 The CRF type 1 receptor (CRFR1) gene
encodes one functional variant (α) in humans and
rodents along with several nonfunctional splice variants.
30-32
The CRF type 2 receptor (CRFR2) has three functional
splice variants in human (α,β,and γ) and two in rodents
(α and β) resulting from the use of alternate 5’ starting
exons.
33,34
CRFR1 is expressed at high levels in the brain and pitu-
itary and low levels in peripheral tissues.The highest lev-
els of CRFR1 expression are found in the anterior pitu-
itary,olfactory bulb,cerebral cortex,hippocampus,and
cerebellum.In peripheral tissues,low levels of CRFR1
are found in the adrenal gland, testis, and ovary.
35,36 In
contrast,CRFR2 is highly expressed in peripheral tissues
and localized in a limited number of nuclei in the brain.
37
In rodents,the CRF type 2α splice variant is preferen-
tially expressed in the mammalian brain and is localized
in the lateral septum,BNST,ventral medial hypothala-
mus,and mesencephalic raphe nuclei.
36The CRF type 2β
variant is expressed in the periphery and is concentrated
in the heart,skeletal muscle,skin,and the gastrointesti-
nal tract.
29,38,39
Radioligand binding and functional assays have
revealed that CRFR1 and CRFR2 have different phar-
macological profiles. CRF binds to the CRFR1 with
higher affinity than to CRFR2.
29,33 Ucn1 has high affin-
ity for both CRFR1 and CRFR2 and is more potent
than CRF on CRFR2.
24,33 Ucn 2 and Ucn 3 are highly
selective for CRFR2 and exhibit low affinities for
CRFR1.In addition,Ucn 2 and Ucn 3 minimally induce
cyclic adenosine monophosphate (cAMP) production
in cells expressing either endogenous or transfected
CRFR1.
25-27
The neuroendocrine properties of CRF are mediated
through CRFR1 in the anterior pituitary. Binding of
CRF to the type 1 receptor results in the stimulation of
adenylate cyclase and a subsequent activation of cAMP
pathway events that culminate with the release of
ACTH from pituitary corticotropes.
29,39,40 The integral
role of CRFR1 in the regulation of ACTH release was
confirmed by the phenotype of CRFR1-deficient mice.
Mice deficient for CRFR1 have a severely attenuated
HPA response to stress and display decreased anxiety-
like behaviors.
41,42 The role of CRFR2 in the regulation
of the HPA axis and adaptive responses to stress is less
clear.Mice deficient for CRFR2 have an amplified HPA
response to stress and display increased anxiety-like
behaviors.
43-45 However, administration of CRFR2 ago-
nists and antagonists into discrete brain regions reveal
both anxiolytic and anxiogenic roles for CRFR2.
45
Vasopressin
Vasopressin (AVP) is a nonapeptide that is highly
expressed in the PVN,supraoptic (SON),and suprachi-
asmatic nuclei of the hypothalamus.
46,47 Magnocellular
neurons of the PVN and SON project to the posterior
lobe of the pituitary and release AVP directly into the
systemic circulation to regulate osmotic homeostasis.
48,49
In addition to magnocellular neurons,parvocellular neu-
rons of the PVN synthesize and release AVP into the
portal circulation, where this peptide potentiates the
effects of CRF on ACTH release from the anterior pitu-
itary.
7,50,51
The synergistic effects of AVP on ACTH release are
mediated through the vasopressin V1b (also known as V3)
receptor on pituitary corticotropes.
52 Binding of AVP to
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385the V1b receptor activates phospholipase C by coupling
to Gq proteins.Activation of the phospholipase C stim-
ulates protein kinase C,resulting in the potentiation of
ACTH release.
53 Several investigators have reported that
the expression of AVP in parvocellular neurons of the
PVN and V1b receptor density in pituitary corticotropes
is significantly increased in response to chronic stress.
54-58
These findings support the hypothesis that AVP plays an
important role in the stress response by maintaining
ACTH responsiveness to novel stressors during periods
of chronic stress.
Adrenocorticotropic hormone
Pro-opiomelanocortin (POMC) is a prohormone that is
highly expressed in the pituitary and the hypothalamus.
POMC is processed into a number of bioactive peptides
including ACTH,β-endorphin,β-lipotropic hormone,and
the melanocortins.
59-61 In response to CRF, ACTH is
released from pituitary corticotropes into the systemic
circulation where it binds to its specific receptor in the
adrenal cortex.ACTH binds to the melanocortin type 2
receptor (MC2-R) in parenchymal cells of the adreno-
cortical zona fasciculata. Activation of the MC2-R
induces stimulation of cAMP pathway events that induce
steroidogenesis and the secretion of glucorticoids,min-
eralcorticoids,and androgenic steroids.
62,63 Specifically,
ACTH promotes the conversion of cholesterol into δ-5
pregnenolone during the initial step of glucocorticoid
biosynthesis.
61,64
Glucocorticoids
Glucocorticoids,cortisol in humans and corticosterone in
rodents, are a major subclass of steroid hormones that
regulate metabolic,cardiovascular,immune,and behav-
ioral processes.
3,4The physiological effects of glucocorti-
coids are mediated by a 94kD cytosolic protein,the glu-
cocorticoid receptor (GR).The GR is widely distributed
throughout the brain and peripheral tissues.In the inac-
tive state,the GR is part of a multiprotein complex con-
sisting of several different molecules of heat shock pro-
teins (HSP) that undergo repeated cycles of dissociation
and ATP-dependent reassociation.
11,65,66 Ligand binding
induces a conformational change in the GR,resulting in
the dissociation of the receptor from the HSP complex
and translocation into the nucleus.Following transloca-
tion,the GR homodimer binds to specific DNA motifs
termed glucocorticoid response elements (GREs) in the
promoter region of glucocorticoid responsive genes and
regulates expression through interaction with transcrip-
tion factors.
11,67,68The GR has also been shown to regulate
activation of target genes independent of GRE-binding
through direct protein-protein interactions with tran-
scription factors including activating protein 1 (AP-1)
and nuclear factor-κB (NF-κB).
69-71
Endocrine regulation of the HPA axis
Activation of the HPA axis is a tightly controlled process
that involves a wide array of neuronal and endocrine sys-
tems.Glucocorticoids play a prominent role in regulat-
ing the magnitude and duration of HPA axis activation.
72
Following exposure to stress,elevated levels of circulat-
ing glucocorticoids inhibit HPA activity at the level of the
hypothalamus and pituitary.The HPA axis is also subject
to glucocorticoid independent regulation.The neuroen-
docrine effects of CRF are also modulated by CRF bind-
ing proteins that are found at high levels in the systemic
circulation and in the pituitary gland.
73,74
Glucocorticoid negative feedback
The HPA axis is subject to feedback inhibition from cir-
culating glucocorticoids.
72 Glucocorticoids modulate the
HPA axis through at least two distinct mechanisms of
negative feedback. Glucocorticoids have traditionally
been thought to inhibit activation of the HPA axis
through a delayed feedback system that is responsive to
glucocorticoid levels and involves genomic alterations.
There is increasing evidence for an additional fast nonge-
nomic feedback system that is sensitive to the rate of glu-
cocorticoid secretion;however,the exact mechanism that
mediates rapid feedback effects has not yet been char-
acterized.
11,72,75
The delayed feedback system acts via transcriptional
alterations and is regulated by GR localized in a number
of stress-responsive brain regions.
76 Following binding of
glucocorticoids, GRs modulate transcription of HPA
components by binding to GREs or through interactions
with transcription factors.
11,72 Glucocorticoids have a low
nanomolar affinity for the GR and extensively occupy
GRs during periods of elevated glucocorticoid secretion
that occur following stress.
77 Mineralocorticoid receptors
(MRs) have a subnanomolar affinity for glucocorticoids,
a restricted expression pattern in the brain,and bind glu-
Basic research
386cocorticoids during periods of basal secretion.
76,77The dis-
tinctive pharmacologies of these two receptors suggest
that MRs regulate basal HPA tone while GRs mediate
glucocorticoid negative feedback following stress.
75,78,79
GRs are widely expressed in the brain,and thus the pre-
cise anatomical locus of glucocorticoid negative feed-
back remains poorly defined. However, two regions of
the brain appear to be key sites for glucocorticoid feed-
back inhibition of the HPA axis. High levels of GR are
expressed in hypophysiotropic neurons of the PVN,and
local administration of glucocorticoids reduce PVN
neuronal activity and attenuate adrenalectomy-induced
ACTH hypersecretion.
80-83 These findings suggest that
the PVN is an important site for glucocorticoid feed-
back inhibition of the HPA axis.The hippocampus has
been implicated as a second site for glucocorticoid neg-
ative feedback regulation of the HPA axis. The hip-
pocampus contains a high concentration of both GR
and MR, and infusion of glucocorticoids into this str-
ructure reduces basal and stress induced glucocorticoid
release.
84-86
CRF binding proteins
Two soluble proteins have been identified that bind the
members of the CRF family of peptides with high affin-
ity.The CRF binding protein (CRF-BP) is a highly con-
served 37kD glycoprotein that binds both CRF and 
Ucn 1 with high affinity.
74,87,88The CRF-BP was originally
identified in maternal plasma where it functions to
inhibit HPA axis activation stemming from the elevated
circulating levels of placenta-derived CRF.
89,90 The 
CRF-BP is highly expressed in the pituitary,and recom-
binant CRF-BP attenuates CRF-induced ACTH release
from dispersed anterior pituitary cells in culture.
74These
findings suggest the CRF-BP may function to sequester
CRF at the level of the pituitary and reduce CRFR
activity.
Our laboratory has recently identified a transcript that
encodes a soluble splice variant of the CRFR2 receptor
(sCRFR2α) in the mouse brain.
73 Soluble CRFR2α is a
predicted 143 amino acid protein generated from a pre-
dicted 143 amino acid protein generated from exons 3-5
of the extracellular domain of CRFR2gene and a unique
38 amino acid hydrophilic C-terminal tail.High levels of
sCRFR2α expression are found in the olfactory bulb,cor-
tex,and midbrain regions that have been shown to express
CRFR1.
36 Recombinant sCRFR2α binds CRF with low
nanomolar affinity and inhibits cellular responses to both
CRF and Ucn 1 in signal transduction assays,
73 suggesting
that sCRFR2α may function as a decoy receptor for the
CRF family of peptides.
Neuronal regulation of the HPA axis
Hypophysiotropic neurons in the PVN are innervated by
a diverse constellation of afferent projections from mul-
tiple brain regions.The majority of afferent inputs to the
PVN originate from four distinct regions:brain stem neu-
rons, cell groups of the lamina terminalis, extra-PVN
hypothalamic nuclei,and forebrain limbic structures.
20,91
These cell groups integrate and relay information regard-
ing a wide array of sensory modalities to influence CRF
expression and release from hypophysiotropic neurons
of the PVN (Figure 2).
Brain stem neurons
Brain stem catecholaminergic centers play an important
role in the regulation of the HPA axis. Neurons of the
nucleus of the solitary tract (NTS) relay sensory infor-
mation to the PVN from cranial nerves that innervate
large areas of thoracic and abdominal viscera.The NTS
also receives projections from limbic structures that reg-
ulate behavioral responses to stress including the medial
prefrontal cortex and the central nucleus of the amyg-
dala.
92Accordingly,neuronal populations in the NTS are
activated following lipopolysaccharide injection,
93,94
hypotension,
95 forced swim, and immobilization stress
paradigms.
96
Stress-receptive neurons in the A2/C2 region of the
NTS densely innervate the medial parvocellular subdi-
vision of the PVN.
97,98 Findings from both in vivo and in
vitro studies demonstrate that catecholaminergic input
represents a major excitatory drive on the HPA axis and
induces CRF expression and protein release through an
α-1 adrenergic receptor-dependent mechanism.
99-101
Nonaminergic NTS neurons also innervate the PVN
and contribute to HPA axis regulation. Glucagon-like
peptide 1 containing neurons in the NTS are activated
by physiological stressors and have been shown to
induce ACTH release in vivo.
102,103 The neuropeptides
somatostatin, substance P, and enkephalin are also
expressed in NTS neurons that innervate the PVN and
have been shown to have regulatory effects on the HPA
axis.
104-106
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387The lamina terminalis
A series of interconnected cell groups including the sub-
fornical organ (SFO), median preoptic nucleus
(MePO), and the vascular organ of the lamina termi-
nalis are localized on the rostral border of the third ven-
tricle and make up the lamina terminalis.
107 Cell groups
of the lamina terminalis lie outside of the blood-brain
barrier and relay information concerning the osmotic
composition of blood to the PVN.
108 The medial parvo-
cellular subdivision of the PVN receives rich innerva-
tion from the SFO and to a lesser extent from the
OVLT and MePO.
109 Neurons in the SFO that project to
the PVN are angiotensinergic,and promote CRF secre-
tion and biosynthesis.
110,111This afferent pathway has par-
allel input to the magnocellular division of the PVN,
and had been hypothesized to serve as a link between
HPA and neurohypophysial activation.
112-114
Hypothalamus
The medial parvocellular subdivision of the PVN
receives afferent projections from γ-aminobutyric acid
(GABA)-ergic neurons of the hypothalamus.
115
Hypophysiotropic neurons of the PVN express GABA-
A receptor subunits
116 and hypothalamic injection of the
GABA-A receptor agonists inhibit glucocorticoid secre-
tion following exposure to stressors.
117,118 These studies
suggest that GABA plays a prominent role in hypothal-
amic stress integration.
Hypothalamus: DMH and POA
GABAergic neurons in the dorsomedial hypothalamic
nucleus (DMH) and preoptic area (POA) project to the
medial parvocellular division of the PVN,and are acti-
vated following exposure to stressors.
115,117 Lesions of
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Figure 2. Depiction of the major brain regions and neurotransmitter groups that supply afferent innervation to the medial parvocel-
lular zone of the paraventricular nucleus (PVN). Cell groups of the nucleus of the solitary tract (NTS) and ventral medulla
(C1) relay visceral information to the PVN though noradrenergic (NE), adrenergic (Epi), and glucagon-like peptide 1 (GLP-1)-
containing neurons. Hypothalamic nuclei (HYPO) encode information from endocrine systems and send mainly γ-aminobu-
tyric acid (GABA)-ergic (GABA) projections to the PVN. Cell groups of the lamina terminalis relay information concerning the
osmotic composition of blood to the PVN through glutamatergic (Glu) and angiotensinergic (Ang) neurons. Limbic struc-
tures including the hippocampus, prefrontal cortex, and the amygdala contribute to the regulation of PVN neurons through
intermediary neurons of the bed nucleus of the stria terminalis (BNST). PIT, pituitary
Adapted from reference 20: Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W. The functional neuroanatomy of corticotropin-releas-
ing factor. Ciba Found Symp. 1993;172:5-21; discussion 21-29. Copyright © John Wiley and Sons 1993.
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Humoral
SFO
(Ang, Glu)hypothalamic regions encompassing the DMH and the
POA amplify HPA responses to stress.
119,120 Furthermore,
glutamate microstimulation of DMH neurons produces
inhibitory postsynaptic potentials in hypophysiotropic
neurons of the PVN,
121 and stimulation of the POA atten-
uates the excitatory effects of medial amygdalar stimu-
lation of glucocorticoid release.
122The POA is a potential
site of integration between gonadal steroids and the HPA
axis.Accordingly,neurons of the POA are activated by
gonadal steroids and express high levels of androgen,
estrogen,and progesterone receptors.
123,124
Hypothalamus: feeding centers
Hypothalamic centers involved in the regulation of energy
homeostasis directly innervate PVN neurons.Neurons in
the arcuate nucleus are sensitive to circulating levels of
glucose,insulin,and leptin These cells also synthesize neu-
ropeptide Y (NPY),agouti-related peptide (AGRP),α-
melanocyte stimulating hormone (αMSH),and cocaine-
and amphetamine-regulated transcript (CART) which play
critical roles in the regulation of feeding behaviors.
125-127 In
addition to their roles in energy homeostasis,arcuate neu-
ropeptides have significant effects on HPA axis activity.
Central injection of the orexigenic factor NPY results in
HPA axis activation
128,129 and infusion of AGRP signifi-
cantly increases CRF release from hypothalamic
explants.
130The anorectic peptides αMSH and CART have
been reported to increase circulating levels of ACTH and
corticosterone,
130-132 induce cAMP binding protein phos-
phorylation in CRF neurons,
133 and stimulate CRF release
from hypothalamic neurons.
130,134These studies suggest that
the HPA axis is activated in response to positive and neg-
ative states of energy balance.
The limbic system
Limbic structures of the forebrain contribute to the reg-
ulation of the HPA axis.Neuronal populations in the hip-
pocampus, prefrontal cortex, and amygdala are the
anatomical substrates for memory formation and emo-
tional responses, and may serve as a link between the
stress system and neuropsychiatric disorders.
86,135The hip-
pocampus,prefrontal cortex,and amygdala have signif-
icant effects on glucocorticoid release and behavioral
responses to stress.
84,136,137 However,these limbic structures
have a limited number of direct connections with
hypophysiotropic neurons of the PVN and are thought
to regulate HPA axis activity through intermediary neu-
rons in the BNST,hypothalamus,and brain stem.
20,138,139
Limbic system: hippocampus
The hippocampus plays an important role in the termi-
nating HPA axis responses to stress.
84,139 Stimulation of
hippocampal neurons decreases neuronal activity in the
parvocellular division of the PVN and inhibits glucocor-
ticoid secretion.
140-142 Hippocampal lesions produce ele-
vated basal levels of circulating glucocorticoids,
143,144
increase parvocellular CRF and AVP expression,
145 and
prolong ACTH and corticosterone release in response to
stress.
141,146
The regulatory effects of the hippocampus on the HPA
axis are mediated through a multisynaptic pathway and
appear to be stressor-specific.
139 Hippocampal outflow to
the hypothalamus originates in the ventricle subiculum
and CA1 regions of the hippocampus.
139,147These regions
send afferent projections to GABAergic neurons of
BNST and the peri-PVN region of the hypothalamus
that directly innervate the parvocellular division of the
PVN.
139,147,148 Hippocampal lesions encompassing the ven-
tral subiculum produce exaggerated HPA responses to
restraint and open field exposure,but not to hypoxia or
ether exposure, suggesting that hippocampal neurons
respond to distinct stress modalities.
146,149,150
Limbic system: prefrontal cortex
The prefrontal cortex also regulates HPA responses to
stress.Neurons of the medial prefrontal cortex are acti-
vated and release catecholamines following exposure to
acute and chronic stressors.
117,151,152 Bilateral lesions of the
anterior cingulate and prelimbic cortex increase ACTH
and glucocorticoid responses to stress,
85,153 demonstrating
that the prefrontal cortex has inhibitory effects on the
HPA axis.Anatomic tracing studies reveal that the there
is an intricate topographic organization of prefrontal cor-
tex output to HPA regulatory circuits.Afferents from the
infralimbic cortex project extensively to the BNST,amyg-
dala,and the NTS.
154,155 In contrast,the prelimbic/anterior
cingulate cortex projects to the POA and the DMH but
fails to synapse with the BNST,NTS,or amygdalar neu-
rons.
139,154,155
The prefrontal cortex may also play a role in glucocor-
ticoid feedback inhibition of the HPA axis.High densi-
ties of GR are expressed in layers II,III,and VI of the
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156 Infusion of glucocorticoids into the
medial prefrontal cortex attenuates ACTH and corticos-
terone responses to restraint stress,but has no significant
effect on HPA responses to ether.
85,157 Similarly to the hip-
pocampus,it appears that neurons of the prefrontal cor-
tex are subject to modality-specific regulation of gluco-
corticoid feedback inhibition of the HPA axis.
139
Limbic system: amygdala
In contrast to the hippocampus and the prefrontal cor-
tex, the amygdala is thought to activate the HPA axis.
Stimulation of amygdalar neurons promotes glucocorti-
coid synthesis and release into the systemic circula-
tion.
158,159The medial (MeA) and central (CeA) nuclei of
the amygdala play a key role in HPA axis activity and
contribute the majority of afferent projections from the
amygdala to cortical,midbrain,and brain stem regions
that regulate adaptive responses to stress.
160,161The MeA
and CeA respond to distinct stress modalities and are
thought to have divergent roles in HPA regulation.
139
Neurons in the MeA are activated following exposure to
“emotional”stressors including predator,forced swim,
social interaction,and restraint stress paradigms.
117,162-165 In
contrast,the CeA appears to be preferentially activated
by “physiological”stressors,including hemorrhage and
immune challenge.
166,167
The CeA exerts its regulatory effects on the HPA axis
through intermediary neurons in the brain stem.
139
Afferent projections from the CeA densely innervate the
NTS and parabrachial nucleus.
92,168The MeA sends a lim-
ited number of direct projections to the parvocellular
division of the PVN
169;however,this subnucleus inner-
vates a number of nuclei that directly innervate the PVN.
Neurons of the MeA project to the BNST, MePO, and
ventral premammillary nucleus.
169
The amygdala is a target for circulating glucocorticoids
and the CeA and MeA express both GR and MR. In
contrast to the effects on hippocampal and cortical neu-
rons,glucocorticoids increase expression of CRF in the
CeA and potentiate autonomic responses to chronic
stressors.Glucocorticoid infusion into the CeA does not
acutely effect HPA activation but may play a feed-for-
ward role to potentiate HPA responses to stress.
139,157,170
Sympathetic circuits and the stress response
Activation of brain stem noradrenergic neurons and sym-
pathetic andrenomedullary circuits further contribute to
the body’s response to stressful stimuli. Similarly to the
HPA axis,stress-evoked activation of these systems pro-
motes the mobilization of resources to compensate for
adverse effects of stressful stimuli.
3,171The locus coeruleus
(LC) contains the largest cluster of noradrenergic neurons
in the brain and innervates large segments of the neu-
roaxis.
172 The LC has been implicated in a wide array of
physiological and behavioral functions including emotion,
vigilance,memory,and adaptive responses to stress.
173-175A
wide array of stressful stimuli activate LC neurons,alter
their electrophysiological activity,and induce norepineph-
rine release.
176-178 Stimulation of the LC elicits several stress-
associated responses including ACTH release,
179 anxio-
genic-like behaviors,
180 and suppression of immune
functions.
181 In addition, there are interactions between
CRF and NE neurons in the CNS.Central administration
of CRF alters activity of LC neurons and NE catabolism in
terminal regions.
13,182 Finally,dysfunction of catecholamer-
gic neurons in the LC has been implicated in the patho-
physiology of affective and stress-related disorders.
183,184
Conclusions
Maintenance of homeostasis in the presence of real or per-
ceived challenges requires activation of a complex range of
responses involving the endocrine,nervous,and immune
systems, collectively known as the stress response.
Inappropriate regulation of the stress response has been
linked to a wide array of pathologies including autoimmune
disease,hypertension,affective disorders,and major depres-
sion.In this review we briefly discussed the major neuronal
and endocrine systems that contribute to maintenance of
homeostasis in the presence of stress.Clearly deciphering
the role of each of these systems and their regulatory mech-
anisms may provide new therapeutic targets for treatment
and prophylaxis of stress-related disorders including anxi-
ety,feeding,addiction,and energy metabolism. ❏
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Función del eje hipotálamo-hipofisis-supra-
renal en las respuestas endocrinas al estrés
Los animales responden al estrés, activando una
amplia gama de respuestas comportamentales y
fisiológicas que se conocen, de forma genérica, como
respuesta al estrés. El factor liberador de corticotro-
pina (CRF) desempeña una misión cardinal en la res-
puesta al estrés, al regular el eje hipotálamo-hipófi-
sis-suprarrenal (HHS). En respuesta al estrés, el CRF
inicia una cascada de acontecimientos que culminan
con la liberación de glucocorticoides por la corteza
suprarrenal. Como consecuencia del elevado número
de efectos fisiológicos y conductuales inducidos por
los glucocorticoides, han surgido varios mecanismos
para controlar la activación del eje HHS e integrar la
respuesta al estrés. La inhibición por retroalimenta-
ción de los glucocorticoides contribuye decisiva-
mente a regular la magnitud y la duración de su libe-
ración. Además de esta retroalimentación
glucocorticoidea, el eje HHS está regulado en el
hipotálamo por un grupo diverso de proyecciones
aferente de los núcleos límbicos, mesencefálicos y del
tronco cerebral. La respuesta al estrés está mediada
también, en parte, por las neuronas noradrenérgicas
del tronco cerebral, los circuitos adrenomedulares
simpáticos y los sistemas parasimpáticos. En resumen,
el objetivo de esta revisión es exponer la importan-
cia del eje HHS en la integración de las respuestas
adaptativas al estrés. Asimismo, se señalan y descri-
ben brevemente los principales sistemas neuronales
y endocrinos que contribuyen a la regulación del eje
HHS y al mantenimiento de la homeostasis frente a
los estímulos adversos. 
Rôle de l’axe hypothalamo-hypophyso-
surrénalien dans les réponses neuro-
endocriniennes au stress
Les animaux répondent au stress en activant un
large panel de réponses comportementales et phy-
siologiques, collectivement considérés comme cons-
tituant la réponse au stress. Le facteur de libération
de corticotrophine (CRF) joue un rôle central dans
la réponse au stress en régulant l’axe hypothalamo-
hypophyso-surrénalien (HPA). Dans la réponse au
stress, le CRF déclenche une cascade d’événements
qui aboutissent à la libération de glucocorticoïdes
à partir du cortex surrénalien. Etant donné le grand
nombre d’effets physiologiques et comportemen-
taux produits par les glucocorticoïdes, plusieurs
mécanismes se sont développés afin de contrôler
l’activation de l’axe HPA et intégrer les réponses au
stress. Le rétrocontrôle inhibiteur des glucocorti-
coïdes joue un rôle essentiel dans l’ampleur et la  la
durée de leur libération. En plus de ce rétro-
contrôle, l’axe HPA est régulé au niveau hypotha-
lamique par différentes projections afférentes pro-
venant du système limbique, du mésencéphale et
des noyaux du tronc cérébral. La réponse au stress
est également transmise en partie par les neurones
noradrénergiques du tronc cérébral, les circuits sym-
pathiques adrénomédullaires et le système
parasympathique. En résumé, cet article a pour but
d’examiner le rôle de l’axe HPA dans l’intégration
des réponses adaptatives au stress. Nous avons aussi
identifié et brièvement décrit les principaux systè-
mes neuronaux et endocriniens qui participent à la
régulation de l’axe HPA et au maintien de l’homé-
ostasie face à des agressions.
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